114 related articles for article (PubMed ID: 11745436)
1. Antisense-mediated reduction in thrombospondin-1 expression reduces cell motility in malignant glioma cells.
Amagasaki K; Sasaki A; Kato G; Maeda S; Nukui H; Naganuma H
Int J Cancer; 2001 Nov; 94(4):508-12. PubMed ID: 11745436
[TBL] [Abstract][Full Text] [Related]
2. Cell density regulates thrombospondin-1 production in malignant glioma cells.
Naganuma H; Satoh E; Kawataki T; Amagasaki K; Satoh H; Nukui H
J Neurooncol; 2003 Jun; 63(2):147-53. PubMed ID: 12825818
[TBL] [Abstract][Full Text] [Related]
3. Participation of thrombospondin-1 in the activation of latent transforming growth factor-beta in malignant glioma cells.
Sasaki A; Naganuma H; Satoh E; Kawataki T; Amagasaki K; Nukui H
Neurol Med Chir (Tokyo); 2001 May; 41(5):253-8; discussion 258-9. PubMed ID: 11396305
[TBL] [Abstract][Full Text] [Related]
4. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
[TBL] [Abstract][Full Text] [Related]
5. L1 stimulation of human glioma cell motility correlates with FAK activation.
Yang M; Li Y; Chilukuri K; Brady OA; Boulos MI; Kappes JC; Galileo DS
J Neurooncol; 2011 Oct; 105(1):27-44. PubMed ID: 21373966
[TBL] [Abstract][Full Text] [Related]
6. Quantification of thrombospondin-1 secretion and expression of alphavbeta3 and alpha3beta1 integrins and syndecan-1 as cell-surface receptors for thrombospondin-1 in malignant glioma cells.
Naganuma H; Satoh E; Asahara T; Amagasaki K; Watanabe A; Satoh H; Kuroda K; Zhang L; Nukui H
J Neurooncol; 2004 Dec; 70(3):309-17. PubMed ID: 15662972
[TBL] [Abstract][Full Text] [Related]
7. VR-10 Thrombospondin-1 Synthetic Polypeptide's Impact on Rhesus Choroid-Retinal Endothelial Cells.
Tian R; Han F; Yang J; Zhao HY; Mei Y; Deng AP; Fang L; Zhang XR
Cell Physiol Biochem; 2018; 46(2):609-617. PubMed ID: 29617696
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity.
Ohnishi T; Arita N; Hiraga S; Taki T; Izumoto S; Fukushima Y; Hayakawa T
Clin Exp Metastasis; 1997 Sep; 15(5):538-46. PubMed ID: 9247256
[TBL] [Abstract][Full Text] [Related]
10. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
Kondraganti S; Mohanam S; Chintala SK; Kin Y; Jasti SL; Nirmala C; Lakka SS; Adachi Y; Kyritsis AP; Ali-Osman F; Sawaya R; Fuller GN; Rao JS
Cancer Res; 2000 Dec; 60(24):6851-5. PubMed ID: 11156378
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of topoisomerase II alpha subunit de novo synthesis by specific antisense oligonucleotides suppresses human glioma T98G cell growth.
Shin M; Kimura S; Nagao S
Neurol Med Chir (Tokyo); 1999 Mar; 39(3):199-204; discussion 204-5. PubMed ID: 10344108
[TBL] [Abstract][Full Text] [Related]
12. Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma.
Castle V; Varani J; Fligiel S; Prochownik EV; Dixit V
J Clin Invest; 1991 Jun; 87(6):1883-8. PubMed ID: 2040684
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma.
Kragh M; Quistorff B; Tenan M; Van Meir EG; Kristjansen PE
Cancer Res; 2002 Feb; 62(4):1191-5. PubMed ID: 11861403
[TBL] [Abstract][Full Text] [Related]
14. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.
Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P
Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757
[TBL] [Abstract][Full Text] [Related]
15. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor.
Silverstein RL; Baird M; Lo SK; Yesner LM
J Biol Chem; 1992 Aug; 267(23):16607-12. PubMed ID: 1379600
[TBL] [Abstract][Full Text] [Related]
16. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
Albo D; Berger DH; Rothman VL; Tuszynski GP
J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene.
Kunapuli P; Chitta KS; Cowell JK
Oncogene; 2003 Jun; 22(26):3985-91. PubMed ID: 12821932
[TBL] [Abstract][Full Text] [Related]
18. Role of stromal thrombospondin-1 in motility and proteolytic activity of oral squamous cell carcinoma cells.
Hayashido Y; Nakashima M; Urabe K; Yoshioka H; Yoshioka Y; Hamana T; Kitano H; Koizumi K; Okamoto T
Int J Mol Med; 2003 Oct; 12(4):447-52. PubMed ID: 12964017
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of c-sis protein synthesis and cell growth with antisense oligonucleotides in human glioma cells].
Nitta T; Sato K
No Shinkei Geka; 1992 Aug; 20(8):857-63. PubMed ID: 1508312
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?
Amodeo V; Bazan V; Fanale D; Insalaco L; Caruso S; Cicero G; Bronte G; Rolfo C; Santini D; Russo A
Expert Opin Ther Targets; 2013 Nov; 17(11):1249-61. PubMed ID: 24053448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
